TECHHIGH SIGNALFINANCIAL10-K

TECH experienced a dramatic deterioration in profitability with net income declining 56% while simultaneously tripling share buybacks to $275.7M, suggesting potential capital allocation concerns amid operational challenges.

The company's operating performance has significantly weakened with both net income and operating income falling by more than 50%, primarily driven by a 26% increase in SG&A expenses. The aggressive increase in share buybacks during a period of declining profitability raises questions about management's capital allocation priorities and whether they are artificially supporting share price rather than addressing underlying operational issues.

Comparing 2025-08-22 vs 2024-08-22View on EDGAR →
FINANCIAL ANALYSIS

TECH's financial performance deteriorated sharply with net income falling 56% to $73.4M and operating income dropping 50% to $102.3M, primarily due to SG&A expenses rising 26% to $588.5M. Despite this weakened profitability, management dramatically increased share buybacks by 245% to $275.7M while cutting capital expenditure in half to $31.0M. The combination of declining earnings, reduced investment in growth (capex), and aggressive share repurchases suggests management may be prioritizing short-term share price support over addressing fundamental operational challenges, which is concerning for long-term value creation.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
+244.5%
$80.0M$275.7M

Share repurchases increased 244.5% — management returning capital, signals confidence in intrinsic value.

Net Income
P&L
-56.3%
$168.1M$73.4M

Net income declined 56.3% — review whether driven by operations, interest costs, or non-recurring items.

Capital Expenditure
Cash Flow
-50.7%
$62.9M$31.0M

Capex reduced 50.7% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Operating Income
P&L
-50.5%
$206.7M$102.3M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

SG&A Expense
P&L
+26.2%
$466.4M$588.5M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Accounts Receivable
Balance Sheet
-14.3%
$241.4M$206.9M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Current Liabilities
Balance Sheet
+10.3%
$159.4M$175.8M

Current liabilities rose 10.3% — increased short-term obligations, watch current ratio.

LANGUAGE CHANGES
NEW — 2025-08-22
PRIOR — 2024-08-22
ADDED
As of August 18, 2025, 155,549,587 shares of the Company s Common Stock ($0.01 par value) were outstanding.
Our broad product portfolio and application expertise enables scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases.
We manage the business in two operating segments our Protein Sciences segment and our Diagnostics and Spatial Biology segment.
Today, our product lines include hundreds of thousands of diverse products, most of which we manufacture ourselves in multiple locations in North America, as well as locations in the U.K., Canada, Switzerland and China.
Recent examples include the investment in Spear Bio at the beginning of fiscal 2025 and the acquisition of Lunaphore SA ( Lunaphore ) at the beginning of fiscal 2024.
+7 more — sign up free →
REMOVED
As of August 16, 2024, 158,600,408 shares of the Company s Common Stock ($0.01 par value) were outstanding.
Investment in our securities involves risk and uncertainty and you should carefully consider all information in this Annual Report on Form 10-K prior to making an investment decision regarding our securities.
Below is a summary of material risks and uncertainties we face, which are discussed more fully in Item 1A.
Our growth depends in part on the timely development and commercialization of new and enhanced products and services that meet our customers needs.
A significant disruption in, or breach of security of, our information technology systems or data, or violation of data privacy laws, could result in damage to our reputation, data integrity, and/or subject us to costs, fines, or lawsuits under data privacy or other laws or contractual requirements.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →